How to choose an aesthetic marketing agency in the USA — 2026 buyer guide with 42-point criteria, red flags and pricing-model comparison
The 2026 Ichelon Consulting US Dallas guide for US medspa, dermatology, plastic surgery and cosmetic practice owners hiring a marketing agency — the 42-point criteria checklist that separates a real aesthetic specialist from a generalist, the eighteen red flags that should end a conversation, the 26 questions to ask before signing, the four pricing models in the market and which one to choose, and the reference-check protocol that actually catches the failure patterns before you sign.
- Score every prospective aesthetic marketing agency on a 42-point checklist across six dimensions — vertical proof, HIPAA and BAA posture, attribution and reporting, pricing transparency, state medical board familiarity, and reference verifiability. Anything below 34 of 42 in an industry with 10,488 US medspa locations and 13,774 dermatology practice locations is a below-median pick.
- Eighteen non-negotiable red flags should end a conversation: refusal to sign a Business Associate Agreement, opaque reporting, guaranteed-ranking promises, template landing pages recycled across competing practices in the same metro, no verifiable case study, undisclosed offshore subcontracting, first-lead hostage clauses, and no FTC 16 CFR §255 fluency.
- Ask 26 structured questions across six categories before signing — vertical proof, HIPAA, reporting, pricing, team, and creative compliance. Any answer that is generic marketing-speak rather than aesthetic-specific is a signal to keep looking.
- Four pricing models dominate: fixed retainer, percentage of spend, hybrid retainer plus performance kicker, and pure performance per booked consultation. A fixed retainer of USD 1,800 to USD 12,000 per month plus a clear performance kicker is the 2026 US aesthetic industry benchmark for single-location practices.
- Every US aesthetic marketing agency must sign a HIPAA Business Associate Agreement under 45 CFR §164.504(e) before touching PHI — because a medspa or derma practice is a covered entity from the first electronic transaction. No BAA equals no engagement, full stop.
- Dallas, Texas LLC
- 10-person US client team · Central Time (CST)
- 25+ US healthcare clients
- BAA signed with every client
- HIPAA compliance training across client and delivery teams
- Contracts and invoices in USD
-
Primary Care · North Dallas, TXCase study →
-
MedSpa · North Dallas, TX
-
Skin Care · Beverly Hills, CA
-
Dental · Christiansburg, VACase study →
-
Pediatrics · Blacksburg, VACase study →
-
Pediatric Dentistry · Blacksburg, VACase study →
-
Dental · Roanoke, VACase study →
-
Functional Medicine · Telehealth · USACase study →
“They were able to get all my ideas and work with me over a period of three to four months and create this amazing website. It's super customized, very modern, and it incorporates all the elements that I had wanted — the patient portal, nice pictures, a very interactive website, patient reviews. I would highly recommend their company to anyone who wants to make an excellent website.”
Why choosing the wrong aesthetic marketing agency is expensive in 2026
The US aesthetic market in 2026 is USD 9.46 billion and growing at 13% compound annual growth rate through 2031 (MarketsAndMarkets). That is a big number, and it has attracted a big field of marketing agencies. The realistic estimate is that several hundred US agencies now claim medspa, dermatology or plastic surgery specialization. A meaningful minority of that field is competent. A larger portion is a generalist digital agency that added an aesthetic vertical page to the website. A small portion is actively dangerous — agencies that have never read the HIPAA Privacy Rule marketing provisions, do not know what the FTC endorsement guides say about before/after imagery, and would happily deploy a testimonial creative that draws a state medical board enquiry inside eight weeks.
The cost of the wrong pick is not just wasted spend. In the US aesthetic vertical, the wrong pick can produce three specific harms: a HIPAA violation that triggers an Office for Civil Rights enquiry, an FTC endorsement rule action, or a state medical board advertising complaint. Any one of those can consume more physician time and more legal budget than the entire agency retainer for eighteen months. This buyer guide exists so US practice owners have a defensible way to pick the right pick.
The 2026 US aesthetic market has 10,488 medspa locations (AmSpa 2026), 13,774 dermatology practice locations (WebMD directory and AAD roster synthesis), and an unmeasured but large plastic surgery practice base per ASPS roster estimates. That is roughly 30,000 US aesthetic-adjacent practice locations chasing the same national and regional agency pool. The economics reward practices that pick well and punish practices that pick on the strength of a well-designed sales deck.
Ichelon Consulting US operates from Dallas, TX — inside the #1 US state for medspa density (Texas at 342 provider locations per AmSpa 2026) and inside one of the top-five metros for aesthetic practice concentration. This guide reflects what we look for when we score our own competitors and what our US practice clients tell us they wish they had asked before their previous engagement.
The 42-point aesthetic marketing agency criteria checklist
Score each prospective agency on this 42-point checklist. The scoring is binary — either the criterion is met with evidence, or it is not. An agency that cannot provide evidence for a criterion does not get credit for it on the basis of assertion. Any total below 34 of 42 is a below-median pick in the US aesthetic vertical in 2026.
Dimension 1 · Vertical proof (10 points)
- Names at least 8 US aesthetic practice clients from the current book of business, with metro and state.
- Can point to at least 5 US aesthetic practices where the retainer has run 12+ months (retention is the honest signal).
- Names at least 3 US aesthetic clients in your specific treatment vertical (medspa, derma, plastic surgery, cosmetic dentistry, hair restoration).
- Names at least 2 US aesthetic clients in your specific state (state medical board familiarity is not fungible).
- Publishes case studies with actual CPQL, CPBC and consult-to-first-treatment conversion — not vanity dashboards.
- Has physician-reviewed content in the portfolio, with named-author byline and Person schema on live URLs.
- Publishes at least one long-form industry report or original data study (a proxy for whether they think about the vertical or just sell into it).
- Names the on-account team by role (strategist, PM, media buyer, content lead) rather than talking about the agency as a monolith.
- Can walk you through their treatment-vertical taxonomy without prompting (injectables sub-classes, energy-based devices, body contouring modalities).
- Knows the AmSpa State of the Industry data, ASDS procedure surveys, and ASPS statistics well enough to cite them accurately.
Dimension 2 · HIPAA and BAA posture (7 points)
- Will sign a Business Associate Agreement under 45 CFR §164.504(e) before onboarding.
- Names a HIPAA-safe analytics stack (server-side GA4 with PHI stripping, HIPAA-configured CRM, BAA-covered call tracking).
- Uses HIPAA-covered tooling by name — CallRail Healthcare, Retreaver HIPAA, JaneApp, Nextech, Modernizing Medicine, Zenoti, Boulevard or equivalent as applicable.
- Has a documented breach response protocol and a named privacy officer or equivalent.
- Knows the December 2022 / March 2024 OCR bulletin on tracking technologies and can explain what they do differently because of it.
- Does not use Meta Personal Attributes fields on aesthetic-treatment landing pages (or explains the compliant workaround in one paragraph).
- Manages Google Ads Enhanced Conversions with hashed identifiers, not raw PHI.
Dimension 3 · Attribution and reporting (7 points)
- Defines CPQL and CPBC in writing, with a qualification rubric you can read before signing.
- Provides a live dashboard you can log into, not a PDF once a month.
- Ingests offline conversions from the practice management system back into Google Ads and Meta Conversions API using hashed identifiers.
- Preserves UTM continuity from ad-click through booking and through first-treatment.
- Reports CPQL, CPBC and consult-to-first-treatment conversion by channel, not just blended.
- Reports at a treatment-vertical granularity, not just at a channel or campaign granularity.
- Can produce a cohort retention curve for existing customers acquired via the agency’s spend.
Dimension 4 · Pricing transparency (5 points)
- Discloses their pricing model in the first two calls, in writing.
- Provides an itemized scope-of-work with hours or deliverables per line item, not a black-box retainer.
- Discloses whether any part of the media spend is marked up, and by how much.
- Discloses whether the retainer covers a percent-of-spend uplift beyond a media threshold.
- Provides a clean exit clause with 30 to 60 day notice and no forced renewal.
Dimension 5 · State medical board familiarity (7 points)
- Can name the top-ten states by aesthetic practice concentration without prompting.
- Knows the difference between Texas Medical Board Chapter 164 and California B&P Code §651 rules on testimonials.
- Has a claim-substantiation protocol for state advertising rules and can show you a redacted example.
- Has run creative in at least 3 US states and can describe how the creative had to vary.
- Knows the state-specific non-physician injector delegation rules for the states you operate in.
- Has FTC 16 CFR §255 endorsement guide fluency, with a before/after protocol you can review.
- Has FDA 21 CFR §202.1 awareness for prescription neuromodulator and filler brand-name references.
Dimension 6 · Reference verifiability (6 points)
- Provides at least 3 named US aesthetic practice references with direct dial phone numbers.
- References are in your treatment vertical and in your state or an adjacent state.
- References have been on the retainer for at least 9 months.
- Agency does not gate the reference conversation through a scheduled call — you can call directly.
- References are not the same three names repeated across every buyer prospect (a phone check with two references at once confirms this).
- Agency welcomes a reverse-reference — being asked to name a client they parted ways with in the last twelve months.
Eighteen red flags that should end a conversation with a US aesthetic agency
Every one of these red flags has, in an ICG audit or ICG buyer conversation, mapped to an outcome that hurt the practice. None of them is a subjective preference — each of them is either a compliance failure mode or an economic failure mode that can be observed before signing.
- Refusal to sign a Business Associate Agreement, or wanting to sign a “lite” version.
- Guaranteed rankings, guaranteed lead volume, or guaranteed CPQL — none of which any real agency can guarantee.
- Opaque reporting — a monthly PDF with vanity metrics and no live dashboard access.
- Template landing pages recycled across competing practices in the same metro (a Google search of the copy tells you).
- No verifiable case study — every case is anonymized, every metric is a percentage, no direct references.
- Undisclosed offshore fulfillment subcontracting, particularly for content and creative production.
- First-lead ownership hostage clauses — the agency retains rights to leads or reviews on contract exit.
- No FTC 16 CFR §255 endorsement guide literacy when discussing before/after or influencer content.
- No FDA 21 CFR §202.1 awareness when discussing prescription neuromodulator or filler creative.
- “We’ll figure out HIPAA later” or any variation that defers the compliance conversation.
- Blank stares on state medical board specifics for the state your practice operates in.
- Reporting that only shows platform-native metrics from Google Ads and Meta Ads — no offline conversion, no CRM-of-truth reconciliation.
- Missing before/after compliance protocol — no written policy on consent, patient-photograph release, or state-specific disclosure.
- One-way lock-in contract terms — automatic renewal without written re-affirmation, or 12+ months with no exit clause.
- Refusal to name the on-account team by name and role.
- Pricing model that shifts materially between the first proposal and the contract.
- Bidding on your competitors’ brand names as a Google Ads tactic without disclosing the compliance and legal risk.
- Pushing SMS or voice campaigns without discussing TCPA prior express written consent under 47 USC 227.
The 26 questions to ask before signing an aesthetic marketing agency
Ask every one of these questions in a working session with the agency, not through an email exchange. The quality of the answer in real time — not the polish of the written response — is the signal.
Category 1 · Vertical proof (5 questions)
- How many US medspa, dermatology or plastic surgery practices are on your current retainer roster, and in which states?
- Can you name three practices in my treatment vertical whose retainer has run more than twelve months?
- What is the median CPQL and CPBC across your US aesthetic book, and how has that trended over the last four quarters?
- Which state medical boards have you worked around, and what specifically changed in your creative because of them?
- Show me one live URL you built for a US aesthetic client that ranks on page one for a commercial-intent query in a top-five metro.
Category 2 · HIPAA (5 questions)
- Will you sign a Business Associate Agreement under 45 CFR §164.504(e) before onboarding, without negotiation on scope?
- What analytics stack do you deploy for HIPAA-safe measurement, and how does PHI get stripped at the edge?
- Which HIPAA-covered vendors are you already under BAA with (call tracking, CRM, marketing automation)?
- How do you handle the December 2022 and March 2024 OCR tracking-technology bulletin on Google Analytics and Meta Pixel deployment for healthcare pages?
- What is your breach response protocol, and who is your named privacy officer or equivalent?
Category 3 · Reporting and attribution (5 questions)
- What is your written definition of a qualified lead and a booked consultation for our practice, and how does the rubric get maintained?
- How do you ingest offline conversions from our practice management system back into Google Ads and Meta Conversions API?
- What is the dashboard I will be able to log into, and what fields will I see in real time?
- How do you preserve UTM continuity from the initial ad click through first-treatment booking?
- How often do you audit reporting for over-counting or double-attribution, and what is the audit protocol?
Category 4 · Pricing (4 questions)
- What is your pricing model, in writing, with the full itemized scope-of-work by line item?
- Is any portion of the media spend marked up, and if so by how much?
- What is the exit clause and the notice period, and what happens to accounts, dashboards and creative assets on exit?
- What is the performance kicker, if any, and what is the qualifying baseline?
Category 5 · Team (4 questions)
- Who specifically will be on my account, by name and role, and where do they sit geographically?
- What is the escalation path when something goes wrong, and how fast is the response SLA?
- What portion of the work is fulfilled by employees versus contractors versus offshore partners?
- Who is the senior reviewer on my account — a physician-facing strategist, not the sales lead who closed me?
Category 6 · Creative compliance (3 questions)
- Show me your before/after content protocol — how do you handle consent, disclosure and state-specific rules?
- Show me your FTC 16 CFR §255 endorsement guide protocol for influencer content — how are material connections disclosed?
- Show me your FDA 21 CFR §202.1 protocol for prescription neuromodulator and filler brand-name content — what fair-balance formats do you use?
The four aesthetic marketing agency pricing models — which to pick in 2026
Four pricing models dominate the US aesthetic agency market in 2026. Each has a defensible use case and each has a specific failure mode. Understanding the trade-off before signing is the single largest lever a practice owner has on cost of marketing over the twelve-month contract horizon.
| Pricing model | Typical range (single-location US aesthetic) | Best for | Failure mode |
|---|---|---|---|
| Fixed monthly retainer | $1,800 - $12,000/mo | Practices that want predictable budgeting; owners who value transparency over aligned upside | Agency has less direct incentive to scale spend; over- or under-scoped work can drift |
| Percentage of media spend | 10% - 20% of managed spend | Larger media budgets ($30k+/mo); scale-oriented practices | Penalizes efficient buying; agency incentive is to spend more, not to spend better |
| Hybrid retainer + performance kicker | $3,500 - $8,000/mo base + kicker | Most single-location and small multi-unit US aesthetic practices in 2026 | Kicker qualification rubric can drift over time if not documented cleanly |
| Pure performance per booked consultation | $180 - $520 per booked consultation | Rare in aesthetic; used mostly on specific verticals like GLP-1 or hair restoration where the funnel is clean | Compliance and lead-quality disputes are frequent; agency owns leads that should be practice-owned |
The 2026 US aesthetic industry benchmark
The most common pricing model across serious 2026 US aesthetic engagements is a fixed retainer with a clear, well-documented performance kicker. The retainer covers strategy, on-page and technical SEO, Google Business Profile operating cadence, physician-reviewed content program, base creative production, and a defined level of paid-media management. The performance kicker triggers when a documented CPQL threshold is beaten or when a booked-consultation baseline is exceeded, with the kicker capped at a percentage of the base retainer to prevent runaway spend on gaming the metric.
Retainer bands by practice profile
- Foundational (USD 1,800-3,500/month): Single-location practice, SEO plus GBP OS, no paid media management, content program at moderate cadence. The right entry point for a practice that has not yet defined a growth thesis.
- Growth (USD 3,500-7,500/month): Single-location or two-location practice, SEO plus GBP OS plus Google Search plus Meta management, content program at scaled cadence, basic YouTube educational program.
- Scale (USD 7,500-12,000/month plus media spend): Multi-unit practice or single-location with aggressive growth thesis, full-service including TikTok where applicable, physician-reviewed content program at aggressive cadence, dedicated AIO capture layer.
- Enterprise (USD 12,000+ per month plus dedicated team): Multi-state franchise or investor-backed rollup, dedicated pod, market-by-market expansion planning, compliance operations layer.
The HIPAA verification protocol for an aesthetic marketing agency
A US aesthetic marketing agency touches Protected Health Information the moment a lead form is submitted through a page they built, the moment a call is recorded through a tracking platform, or the moment appointment data flows through a CRM they configured. Every one of those surfaces requires a Business Associate Agreement under 45 CFR §164.504(e). No BAA equals no engagement.
Beyond the BAA itself, run a five-step verification protocol before signing:
- Step 1 · Analytics stack review. Ask which analytics implementation they will deploy on your site. The compliant 2026 pattern is server-side GA4 with PHI stripping at the edge, not client-side GA4 with default event capture. If they cannot describe the difference, they are not HIPAA-competent for the aesthetic vertical.
- Step 2 · Tag inventory. Ask for a current tag inventory on their existing US aesthetic client sites. If the inventory includes Meta Pixel with default configuration on treatment-specific landing pages, that is a red flag under the 2022 and 2024 OCR bulletins on tracking technology.
- Step 3 · BAA-covered vendor list. Ask which vendors they use for call tracking (CallRail Healthcare or Retreaver HIPAA are the 2026 defaults), CRM (Nextech, Modernizing Medicine, JaneApp, Zenoti or Boulevard depending on vertical), and marketing automation. Each of those vendors must be under BAA.
- Step 4 · Meta and Google conversion protocol. Ask how they handle Google Ads Enhanced Conversions and Meta Conversions API in a HIPAA-safe pattern. The compliant answer is hashed-identifier upload with PHI stripping on the practice-management-system export, not raw form-field forwarding.
- Step 5 · Meta Personal Attributes and Special Ad Categories. Ask whether their US aesthetic clients’ Meta accounts are configured under the Housing/Employment/Credit special ad category exclusions or the health-related creative approval process. Ask how they handle Meta’s ban on Personal Attributes creative on health topics.
BAA-covered vendor list for US aesthetic marketing (2026)
| Category | Vendor examples (BAA-eligible) | Notes |
|---|---|---|
| Call tracking | CallRail Healthcare, Retreaver HIPAA, PatientEngage | Standard non-HIPAA CallRail is NOT BAA-covered; specify Healthcare edition |
| CRM (practice management) | Nextech, Modernizing Medicine, JaneApp, Zenoti, Boulevard, Aesthetic Record | All BAA-eligible under standard enterprise contract |
| Marketing automation | HIPAA-configured providers (with executed BAA) | Most general-purpose ESPs are NOT BAA-eligible without a specific health tier |
| Analytics | Server-side GA4 via GTM Server Container, HIPAA-configured heat mapping tools | Default client-side GA4 with health-topic pageview capture is a documented risk |
| Ad platforms | Google Ads Enhanced Conversions with hashed IDs; Meta CAPI with hashed IDs | Neither Google nor Meta is a BAA-signing entity; the compliance is at the identifier layer |
| Chatbot / lead capture | HIPAA-tiered providers with executed BAA | Do not deploy general-purpose chat on treatment-specific pages without BAA |
What we found when we studied 555 US med spas on Google
Patients praise the care almost without exception. The one area where complaints outnumber praise is booking and communication, and that is where most med spas can win.
Full study · 555 US med spas across 20 metros · roughly ±4% nationally · review velocity and themes from a 115-spa subsample · verified against raw data.
Attribution proof requirements — what the reporting has to actually show
Attribution is the single most-abused word in the US aesthetic marketing agency conversation. Every agency has a “reporting dashboard.” A meaningful minority has actual attribution — the ability to trace a booked consultation and first-treatment revenue back to the specific ad click or organic session that produced it, with UTM continuity preserved through the practice management system and back to the ad platforms.
The four attribution surfaces that must be intact
- Surface 1 · Click-to-lead. UTM parameters preserved from the ad click through the lead form submission, with the source of truth stored in the CRM. No exceptions for phone leads — call tracking must pass a click identifier or a dynamic number back to the lead record.
- Surface 2 · Lead-to-consultation. Consultation booking data must join back to the lead source. That is a CRM-to-practice-management integration; not a spreadsheet reconciliation.
- Surface 3 · Consultation-to-first-treatment. First-treatment revenue must join back to the lead source through the practice management system. This is the single most-important number in a US aesthetic growth plan; do not tolerate a report that stops at booked consultation.
- Surface 4 · Return-to-platform. Offline conversions must be pushed back into Google Ads Enhanced Conversions and Meta Conversions API using hashed identifiers so the ad platforms can optimize on real outcomes rather than on click-through.
Six numbers a real attribution report shows
- CPQL by channel (Google Search, Google Business Profile, Meta, TikTok, YouTube, organic, referral) with the qualification rubric documented.
- CPBC by channel with same source-of-truth.
- Consult-to-first-treatment conversion by channel, not just blended.
- First-treatment revenue by channel and by treatment vertical.
- Retention curve at 90, 180 and 365 days by channel of acquisition.
- LTV to CAC ratio by channel with underlying inputs shown.
The reference-check protocol that actually catches the failure patterns
Reference checks are the buyer’s most-under-utilized protection. Every agency provides references; a meaningful minority of buyers ever calls them beyond a 5-minute chat. The reference-check conversation is where the failure modes an agency does not want to discuss actually surface.
Call 3 references, not 1
A single reference call is a coached endorsement. Three calls with structured questions triangulates the honest signal. Ask for references in your vertical, one in your state and one out-of-state, one on the retainer 12+ months, and one recent onboarding.
Direct dial, not scheduled
A reference call gated through a scheduled agency-mediated slot is a signaled reference. Ask for direct dial phone numbers. Call in the morning; if the reference is real, they will pick up or return the call inside a day.
15-minute minimum
A reference conversation shorter than fifteen minutes has not scratched the surface. Ask about the onboarding, month three, month six, month twelve, the specific failure mode that surfaced, and how it was resolved. Silence in that conversation is data.
Ask about the parting client
The most valuable reference is the client the agency parted ways with. Ask the agency to name a client whose retainer ended in the last twelve months and why. An agency that refuses to name one is either brand-new or hiding a pattern.
Nine reference-check questions
- What was your CPQL and CPBC in the six months before the agency started, and what are they now?
- How does the agency handle a HIPAA scare — has that ever happened, and how was it resolved?
- How responsive is the on-account team when something goes wrong — not when everything is on plan?
- Has the agency ever caused a state medical board enquiry or an FTC endorsement flag through creative choices?
- What is the one thing you wish had been different at the start of the engagement?
- Would you extend the contract on the current terms, and if not, what would you change?
- Does the on-account team feel senior enough for the size of your practice, or has the account been juniorized over time?
- How would you rate the reporting — is it real attribution or is it a platform-metric roll-up?
- If you could restart the engagement, what would you insist on in the contract that you did not the first time?
State medical board matrix — what your agency has to know
A US aesthetic marketing agency serving a multi-state practice, or serving a single-state practice in a stricter state, must know the specific advertising rules of each state medical board involved. The matrix below covers the top-ten US aesthetic states by practice volume; each state has additional specifics that a competent agency will name in a working session.
| State | Advertising rule anchor | What a competent agency must know |
|---|---|---|
| California | Business & Professions Code §651 | Strict presumption of false-and-misleading; superlatives treated as presumptively false without substantiation binder |
| Texas | Texas Medical Board Chapter 164 | Specific rules on before/after imagery, testimonials, and non-physician injector supervision disclosures |
| Florida | Florida Board of Medicine cosmetic-advertising rules | Before/after warning language required; testimonial disclaimer specifics; office of surgery accreditation implications for advertising |
| New York | NY Public Health Law §238; Corporate Practice of Medicine | PC / PLLC structure implications; fee-disclosure rules; testimonial-adjacent scrutiny |
| Georgia | Composite Medical Board advertising rules | Provider-credential disclosure rules; supervising physician-of-record disclosure on medspa ads |
| Arizona | ARS §32-1401 and §32-1454 | Medspa-specific advertising rules and physician-of-record requirements; strict on injector supervision disclosures |
| Tennessee | Tennessee Board of Medical Examiners rules | Advertising must reflect actual scope; APRN collaboration rules apply to creative claims |
| Illinois | Illinois Medical Practice Act §22 | Advertising rules on qualifications; Medical Corporation Act implications for entity naming in ads |
| Washington | WAC 246-919 | Specific rules on testimonials, discount advertising, and superlatives; strict on physician-credential disclosure |
| Massachusetts | 243 CMR 2.07 | Strict CPOM enforcement implications for ad copy; specific advertising disclosure requirements |
Federal compliance envelope — six statutes the agency must handle
A competent US aesthetic marketing agency clears federal compliance across six statutes as a baseline before any state-specific work. The six are HIPAA, TCPA, CAN-SPAM, ADA, FTC 16 CFR §255 and FDA 21 CFR §202.1.
HIPAA — the covered-entity default
A US aesthetic practice is a HIPAA covered entity from the moment it transmits any health information electronically in connection with a HIPAA transaction. That is essentially every US aesthetic practice in 2026. The marketing agency inherits Business Associate obligations under 45 CFR §164.504(e) the moment it touches PHI, which happens the moment a lead form or a call tracker is deployed on a page they own.
TCPA — the SMS envelope
SMS is the highest-converting aesthetic channel and also the highest-liability. TCPA statutory damages sit at USD 500 to USD 1,500 per unsolicited message under 47 USC §227. The 2026 baseline is prior express written consent for marketing, functioning STOP handling, quiet-hours compliance to recipient time zone, and documented consent capture. An agency that discusses SMS without discussing TCPA is disqualified on that criterion alone.
CAN-SPAM — the email envelope
CAN-SPAM is not a consent regime like TCPA — commercial email may be sent without prior consent as long as the message is not deceptive, includes accurate header and subject, discloses the message as commercial, includes a valid physical postal address, and honors opt-outs within ten business days. The failure modes are transactional-vs-promotional classification, honoring opt-outs across databases, and preheader honesty on subject lines.
ADA — the accessibility envelope
The Department of Justice’s April 2024 rule confirmed that Title II digital accessibility follows WCAG 2.2 AA for state and local government; private-sector Title III enforcement continues to rely on court interpretation, with WCAG 2.2 AA the de facto benchmark. An aesthetic website that fails color contrast, keyboard navigation, or alt-text on before/after imagery is a demand-letter target.
FTC 16 CFR §255 — endorsements and before/after
Every material connection between practice and endorser must be disclosed. Typical-results disclaimers are not a substitute for actually typical results. The 2023 revision to the endorsement guides sharpened the position on hidden compensation and on artificially amplified reviews. Before/after imagery must be truthful, unaltered in material respects, and representative of typical outcomes.
FDA 21 CFR §202.1 — prescription drug advertising
Any brand-name reference to a prescription neuromodulator or filler in marketing content triggers FDA advertising rules — fair balance, brief summary or reference to full prescribing information, and either full-scope or reminder-ad formats. The safest default is treatment-category messaging for programmatic reach, with brand-name creative reserved for permission-based channels where compliant fair-balance can be delivered.
The US practice base
Ichelon Consulting US operates from Dallas, TX — inside the #1 US state for medspa density and one of the top-five metros for aesthetic practice concentration. Every engagement is HIPAA-scoped under a signed BAA, state medical board-vetted, and CPQL-benchmarked against the ranges published in our companion 2026 US aesthetic CPQL benchmarks report.
Backed by ICG global leadership
Every US aesthetic engagement has direct line-of-sight to the Ichelon Consulting US Leadership Team and a senior reviewer with scaled experience in US medspa and dermatology growth, compliance and multi-market rollup dynamics.
Our own tools run inside every engagement
Ichelon Consulting US uses software built by our own product team. Practices can also use most tools on their own, billed in USD.
Choosing a US aesthetic marketing agency — common questions
How do I choose the right aesthetic marketing agency for my US practice in 2026?
Score prospective agencies against a 42-point checklist across six dimensions — vertical proof, HIPAA and BAA posture, attribution and reporting, pricing transparency, state medical board familiarity, and reference verifiability. A total below 34 of 42 is below-median in a market with 10,488 medspa and 13,774 dermatology practice locations chasing the same agency pool.
What questions should I ask an aesthetic marketing agency before signing?
Twenty-six structured questions across six categories — vertical proof, HIPAA, reporting, pricing, team and creative compliance. The quality of the answers in a live 90-minute session tells you more than a 40-page RFP response.
How much should a US medspa or dermatology practice pay for marketing agency retainers in 2026?
USD 1,800 to USD 12,000 per month for a single-location practice depending on scope. Foundational engagements start at USD 1,800-3,500; full-service programs with paid media typically USD 5,000-12,000 plus media spend.
What are red flags when choosing a US aesthetic marketing agency?
Eighteen red flags: refusal to sign a BAA, opaque reporting, guaranteed rankings, template landing pages, undisclosed offshore fulfillment, first-lead hostage clauses, no FTC endorsement literacy, missing before/after protocol, and one-way lock-in contract terms are the leading eight.
Does my US aesthetic marketing agency need to sign a HIPAA Business Associate Agreement (BAA)?
Yes, without exception. Any agency touching PHI must sign a BAA under 45 CFR §164.504(e) before engagement start. Refusal to sign disqualifies the agency.
How should a US aesthetic marketing agency prove attribution?
Source-of-truth booking data through a HIPAA-safe call-tracking platform, CRM with UTM continuity, and offline conversion import back to Google Ads Enhanced Conversions and Meta CAPI using hashed identifiers. Screen-scraped platform dashboards are not attribution.
What pricing models do US aesthetic marketing agencies use?
Fixed retainer, percentage of media spend, hybrid retainer plus performance kicker, and pure performance per booked consultation. Fixed retainer plus documented performance kicker is the 2026 US aesthetic industry benchmark for single-location practices.
How do I check aesthetic marketing agency references correctly?
Call three named references directly, not through scheduled slots; run a 15-minute minimum conversation each; ask about parting clients and how the agency handles compliance scares.
What is the average contract length for an aesthetic marketing agency in 2026?
Six to twelve months with 30 to 60 day notice-of-termination. A 90-day pilot followed by a 12-month primary term with 60-day notice is the balanced baseline.
Should I hire a local aesthetic agency in my metro or a specialist national agency?
Aesthetic-vertical depth beats geographic proximity in 2026. A national aesthetic specialist with real practice count typically outperforms a generalist local agency on CPQL and on compliance defensibility.
Scope a US aesthetic engagement with Ichelon Consulting US
Book a 30-minute call with a member of the Leadership Team, email the US practice lead in Dallas, or reach us by phone. Retainers are custom-scoped per engagement · from USD 1,800/month equivalent for foundational SEO + GBP OS. Every engagement starts with a signed BAA.
Continue the US aesthetic stack
Healthcare brands ICG
has worked with.
A representative slice of the 150+ healthcare brands ICG has delivered for across India. Full client list available under NDA during a Brand and Growth Diagnostic.
